Pharmaceuticals

Single-Cell Omics Market Analysis With Focus On Growth Potential And Future Outlook

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Single-Cell Omics Market Between 2026 And 2030?

The single-cell omics market has experienced substantial expansion in recent times. It is projected to increase from $2.39 billion in 2025 to $2.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.3%. Historically, this growth has been fueled by factors such as advancements in next-generation sequencing, a rise in academic research funding, expanding cancer research programs, the demand for cellular heterogeneity analysis, and improvements in cell isolation technologies.

The single-cell omics market is projected to experience substantial expansion in the coming years. This market is set to reach $5.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. Factors contributing to this anticipated growth include the broadening of precision medicine initiatives, the incorporation of AI into omics analysis, increased investments in pharmaceutical research and development, growing acceptance in clinical diagnostics, and the creation of economical single-cell platforms. Key trends anticipated during this period encompass the increasing use of multi-omics strategies, a heightened need for high-resolution cellular examination, the expansion of single-cell applications within oncology research, a greater reliance on microfluidics for cell isolation, and the standardization of workflows for single-cell analysis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Factors Are Influencing The Growth Of The Single-Cell Omics Market?

Increased instances of cancer are anticipated to drive expansion in the single-cell omics market moving ahead. Cancer refers to a group of diseases that manifest when abnormal cells multiply without regulation, extending beyond their normal limits and potentially invading nearby tissues or spreading to different organs within the body. Single-cell omics data has been extensively utilized for identifying biomarkers relevant to cancer diagnosis, predicting prognosis, and uncovering new therapeutic targets within established clinical groups. For example, data from May 2024, provided by the National Institutes of Health, a US-based government agency, indicated that around 18.1 million people in the United States were cancer survivors as of January 2022. This figure is projected to increase to 22.5 million by 2032. Consequently, the increasing incidence of cancer is fueling the expansion of the single-cell omics market.

Which Segment Types Are Examined In The Single-Cell Omics Market Segment Study?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Shaping Growth In The Single-Cell Omics Market?

Leading companies in the single-cell omics market are concentrating on developing advanced kits, such as sequencing kits, for single-cell applications, aiming to boost their revenues in the market. Sequencing kits consist of pre-packaged sets of reagents and materials specifically designed for genetic sequencing processes, thereby streamlining laboratory workflows. For instance, in February 2023, Singular Genomics Systems, Inc., a US-based company leveraging novel next-generation sequencing (NGS) technology, introduced the Max Read Kits for single-cell sequencing on its G4 Sequencing Platform. These Max Read Kits are engineered for compatibility with popular 10x Genomics assays and offer flexibility for sequencing 4 to 16 samples per run. The kits deliver 800 million reads per flow cell, achieving 80% to 90% Q30 quality. Furthermore, Singular Genomics enhances the quality specifications of the G4 Sequencing Platform’s F2 and F3 flow cells, reaching up to 1.8 billion reads per run on the F3 flow cells for specific applications.

Which Players Are Part Of The Competitive Landscape Of The Single-Cell Omics Market?

Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

Get The Full Single-Cell Omics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which Region Is The Top Contributor To The Single-Cell Omics Market By Share?

North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Single-Cell Omics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Browse Through More Reports Similar to the Global Single-Cell Omics Market 2026, By The Business Research Company

Single Cell Omics Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Single Cell Analysis Market 2026

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Single Cell Genome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795